Applying phage display techniques, we identified a peptide target for IGF2BP2, which was confirmed to be highly expressed in ESCC cell lines or tumor tissue and may serve as an imaging target for ESCC. The gene discussed is IGF2BP2; the disease is esophageal squamous cell carcinoma.